Table 4. Knowledge of Recommended Follow-up of Abnormal Cancer Screening Test Results for Specific Clinical Scenarios From Survey Instrument.

Clinical scenario: recommended window for follow-up for an abnormal resulta	Correct response, No. (%)
Breast cancer screening
55-y-old Woman with a mammogram with a BI-RADS 5 result: 3 mo	239 (86.9)
55-y-old Woman with a mammogram with a BI-RADS 3 result: 6 mo	143 (52.0)
Colorectal cancer screening
60-y-old Man with positive FIT/FOBT: 3 mo	251 (91.3)
65-y-old Man with 10 or more adenomatous polyps: 1 y	141 (51.3)
70-y-old Man with a single 1.5-cm adenomatous polyp: 3 y	105 (38.2)
Cervical cancer screening
33-y-old Woman with HSIL Papanicolaou test, HPV positive and no history of abnormal screening results: 3 mo	219 (79.6)
23-y-old Woman whose first Papanicolaou test shows ASCUS with a negative HPV test: 1 y	160 (58.2)
Lung cancer screening
60-y-old Man with a low-dose lung CT with a Lung-RADS 4b result: 3 mo	189 (68.7)
60-y-old Man with a low-dose lung CT with a Lung-RADS 3 result: 6 mo	144 (52.4)

Abbreviations: ASCUS, atypical squamous cells of undetermined significance; BI-RADS, Breast Imaging Reporting and Data System; CT, computed tomography; FIT/FOBT, fecal immunochemical test/fecal occult blood test; HPV, human papilloma virus; HSIL, high grade squamous intraepithelial lesion; Lung-RADS, Lung Imaging Reporting and Data System.

^a “How soon after each of these abnormal results would you typically recommend a follow-up test or referral for specialist consultation?”